Statement on U.S. Settlement Program
DePuy and the Court-appointed committee of lawyers representing ASR™ Hip System plaintiffs have reached an agreement to effectively extend the benefits of the existing U.S. Settlement Program to include eligible ASR patients in the U.S. who had surgery to replace their ASR hip after August 31, 2013, and on or before January 31, 2015. The existing U.S. Settlement Program was announced in November 2013 and has compensated eligible ASR patients in the U.S. who had surgery to replace their ASR hip as of August 31, 2013.
“By effectively extending the benefits of the previously announced U.S. Settlement Program to an additional group of ASR patients, we are again providing fair compensation to U.S. ASR patients without the delay and uncertainty of protracted litigation,” said Mindy Tinsley, a spokeswoman for DePuy. “DePuy has been committed to the well-being of ASR patients worldwide, and the company continues to advance innovative treatment options to serve those who need joint replacement surgery.”
An estimated 1,400 ASR patients may be eligible to enroll in this settlement program. Detailed information will be available from the program claims processor at www.USASRHipSettlement.com or by calling (877) 391-3169.
The existing U.S. Settlement Program has now resulted in payments for the vast majority of the more than 7,500 patients who enrolled.
In August 2010, DePuy issued a voluntary recall of the ASR Hip System after receiving new information from the UK National Joint Registry as part of the company’s ongoing surveillance of post-market data concerning the ASR Hip System, which showed a revision rate that was not in line with data previously reported in that registry. The product continues to perform well in some patients. Since the recall decision was made, DePuy has worked to provide patients and surgeons with the information and support they need, including the global program providing support for recall-related care, which has thus far resulted in thousands of payments to patients.